Now totaling $227M, Arcus Biosciences announced it had closed a $107M Series C financing. Source: BioSpace

Neurotoxicity killed JCAR015 right along with 5 patients in the lead pivotal study, derailing Juno Therapeutics. Source: BioSpace

Investors in beleaguered Argos are smiling this morning after the company announced some positive interim data for its Phase III kidney cancer drug, Rocapuldencel-T - a trial that some said…

Less than one month after announcing plans for construction of a South Carolina manufacturing facility, Arthrex announces its plans for the expansion of its global headquarters in Florida. Source: BioSpace

Abeona Therapeutics has plans to expand its facilities and hire an additional 25 to 40 employees. Source: BioSpace

ImmunoMolecular Therapeputics officially launched yesterday. Source: BioSpace

Sangamo is moving its corporate headquarters to a new site at Oyster Point in Brisbane, CA. Source: BioSpace

The FDA approved Dynavax's Heplisav-B, it's first new hepatitis B vaccine in the U.S. in more than 25 years. Source: BioSpace

BMS is pushing forward with its internal IDO1 program and showing off early-stage data from its Phase I/IIa combination trial of Opdivo plus BMS-986205, an IDO1 inhibitor. Source: BioSpace

Valeant is not the only company to recently push reporters to defy the SEC’s orders. Source: BioSpace